W. Timothy Garvey

24.8k total citations · 9 hit papers
164 papers, 14.4k citations indexed

About

W. Timothy Garvey is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, W. Timothy Garvey has authored 164 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Endocrinology, Diabetes and Metabolism, 54 papers in Molecular Biology and 54 papers in Physiology. Recurrent topics in W. Timothy Garvey's work include Diabetes Treatment and Management (44 papers), Pharmacology and Obesity Treatment (44 papers) and Diet and metabolism studies (39 papers). W. Timothy Garvey is often cited by papers focused on Diabetes Treatment and Management (44 papers), Pharmacology and Obesity Treatment (44 papers) and Diet and metabolism studies (39 papers). W. Timothy Garvey collaborates with scholars based in United States, United Kingdom and Canada. W. Timothy Garvey's co-authors include Daniel L. Hurley, Jeffrey I. Mechanick, Cristina Lara‐Castro, Penny Wallace, Robert F. Kushner, Richard L. Klein, Alan J. Garber, Stacy A. Brethauer, Ted D. Adams and Adrienne Youdim and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

W. Timothy Garvey

158 papers receiving 13.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity

2016 1.2k citations W. Timothy Garvey, Daniel L. Hurley et al. Endocrine Practice profile →
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*

2013 1.2k citations Jeffrey I. Mechanick, Adrienne Youdim et al. Obesity profile →
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity

2021 646 citations Thomas A. Wadden, Timothy S. Bailey et al. JAMA profile →
Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery

2013 520 citations Jeffrey I. Mechanick, Adrienne Youdim et al. Surgery for Obesity and Related Diseases profile →
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

2011 501 citations W. Timothy Garvey, Donna H. Ryan et al. American Journal of Clinical Nutrition profile →
Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)

2011 486 citations David B. Allison, Kishore M. Gadde et al. Obesity profile →
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

2022 469 citations W. Timothy Garvey, Rachel L. Batterham et al. Nature Medicine profile →
Strengths and Limitations of BMI in the Diagnosis of Obesity: What is the Path Forward?

2024 104 citations W. Timothy Garvey, Cátia Martins et al. profile →
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity

2025 37 citations W. Timothy Garvey, Melanie J. Davies et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Timothy Garvey United States	57	5.6k	5.1k	4.0k	3.3k	3.0k	164	14.4k
Luc F. Van Gaal Belgium	39	5.6k 1.0×	4.3k 0.9×	2.6k 0.7×	4.5k 1.4×	2.2k 0.7×	164	13.7k
Louis J. Aronne United States	50	5.0k 0.9×	5.0k 1.0×	2.9k 0.7×	5.2k 1.6×	1.5k 0.5×	196	12.6k
John P. Kirwan United States	69	4.5k 0.8×	8.8k 1.7×	7.4k 1.9×	1.1k 0.3×	3.5k 1.2×	309	21.8k
Nick Finer United Kingdom	52	3.1k 0.5×	3.8k 0.8×	2.5k 0.6×	3.2k 1.0×	1.0k 0.3×	191	9.9k
André Scheen Belgium	67	10.7k 1.9×	3.9k 0.8×	4.5k 1.1×	3.6k 1.1×	5.3k 1.8×	759	19.9k
Sudhesh Kumar United Kingdom	68	4.1k 0.7×	4.5k 0.9×	1.9k 0.5×	1.1k 0.3×	3.2k 1.1×	238	14.7k
Carel W. le Roux Ireland	71	7.1k 1.3×	11.4k 2.3×	10.5k 2.6×	3.4k 1.0×	3.4k 1.1×	514	23.3k
André Tchernof Canada	62	5.6k 1.0×	6.4k 1.3×	2.7k 0.7×	949 0.3×	3.2k 1.1×	327	17.5k
Pirjo Ilanne‐Parikka Finland	37	6.6k 1.2×	4.3k 0.8×	1.4k 0.4×	1.1k 0.3×	2.2k 0.7×	71	12.9k
Sean Wharton Canada	28	4.8k 0.9×	2.6k 0.5×	2.0k 0.5×	3.5k 1.1×	1.8k 0.6×	94	8.3k

Countries citing papers authored by W. Timothy Garvey

Since Specialization

Citations

This map shows the geographic impact of W. Timothy Garvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Timothy Garvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Timothy Garvey more than expected).

Fields of papers citing papers by W. Timothy Garvey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Timothy Garvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Timothy Garvey. The network helps show where W. Timothy Garvey may publish in the future.

Co-authorship network of co-authors of W. Timothy Garvey

This figure shows the co-authorship network connecting the top 25 collaborators of W. Timothy Garvey. A scholar is included among the top collaborators of W. Timothy Garvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Timothy Garvey. W. Timothy Garvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martins, Cátia, David R. Bryan, W. Timothy Garvey, et al.. (2025). The impact of a low‐carbohydrate (vs. low‐fat) diet on fat mass loss in African American women is modulated by insulin sensitivity. Obesity. 33(2). 257–266. 2 indexed citations

Hankosky, Emily R., et al.. (2025). Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison. Diabetes Obesity and Metabolism. 27(7). 3757–3765. 3 indexed citations

Berg, Karin J. Borgonjen‐van den, W. Timothy Garvey, Amy M. Goss, et al.. (2025). Study protocol, menu design, and rationale for a study testing the effects of a whole fruit-rich diet on glycemic control, liver fat, pancreatic fat, and cardiovascular health in adults with type 2 diabetes. Nutrition Research. 135. 82–100.

Gower, Barbara A., et al.. (2025). Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism. The Journal of Clinical Endocrinology & Metabolism. 111(1). e134–e141.

Garvey, W. Timothy, Peter Dahl, Shuaiqi Guo, et al.. (2024). Outer membrane vesicles and the outer membrane protein OmpU govern Vibrio cholerae biofilm matrix assembly. mBio. 15(2). e0330423–e0330423. 20 indexed citations

Nadolsky, Karl, Monica Agarwal, Jaime P. Almandoz, et al.. (2023). American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity. Endocrine Practice. 29(6). 417–427. 31 indexed citations

Hankosky, Emily R., Hui Wang, Lisa M. Neff, et al.. (2023). Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT ‐1 trial. Diabetes Obesity and Metabolism. 25(12). 3748–3756. 25 indexed citations

Kim, Nina, et al.. (2023). Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020. Journal of Medical Economics. 26(1). 376–385. 4 indexed citations

Kushner, Robert F., W. Timothy Garvey, Dan Hesse, et al.. (2022). Abstract 9: Once-weekly subcutaneous semaglutide 2.4 mg reduces body weight in adults with overweight or obesity regardless of baseline characteristics (STEP 1). Indian Journal of Endocrinology and Metabolism. 26(Suppl 1). S9–S9. 1 indexed citations

10.

Martin, Samantha L., et al.. (2022). Associations Among Physical Activity, Adiposity, and Insulin Resistance in Children Exposed In Utero to Maternal Obesity With and Without Gestational Diabetes. Pediatric Exercise Science. 35(3). 165–173.

11.

Garvey, W. Timothy, Rachel L. Batterham, Silvio Buscemi, et al.. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 28(10). 2083–2091. 469 indexed citations breakdown →

12.

Wadden, Thomas A., Timothy S. Bailey, Liana K. Billings, et al.. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity. JAMA. 325(14). 1403–1403. 646 indexed citations breakdown →

13.

Kushner, Robert F., et al.. (2021). Building Successful Models in Primary Care to Improve the Management of Adult Patients with Obesity. Population Health Management. 24(5). 548–559. 4 indexed citations

14.

Garvey, W. Timothy, Andreas L. Birkenfeld, Dror Dicker, et al.. (2020). Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes Care. 43(5). 1085–1093. 139 indexed citations

15.

Garvey, W. Timothy. (2019). Illuminating the Roles of Outer Membrane Proteins and Outer Membrane Vesicles in Vibrio Cholerae Biofilm. eScholarship (California Digital Library). 1 indexed citations

16.

Guo, Fangjian, Douglas R. Moellering, & W. Timothy Garvey. (2014). Use of HbA1c for Diagnoses of Diabetes and Prediabetes: Comparison with Diagnoses Based on Fasting and 2-Hr Glucose Values and Effects of Gender, Race, and Age. Metabolic Syndrome and Related Disorders. 12(5). 258–268. 100 indexed citations

17.

Mechanick, Jeffrey I., Adrienne Youdim, Daniel B. Jones, et al.. (2013). Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surgery for Obesity and Related Diseases. 9(2). 159–191. 520 indexed citations breakdown →

18.

Garvey, W. Timothy, Donna H. Ryan, Michelle Look, et al.. (2011). Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. American Journal of Clinical Nutrition. 95(2). 297–308. 501 indexed citations breakdown →

19.

Alish, Carolyn J., W. Timothy Garvey, Kevin C. Maki, et al.. (2010). A Diabetes-Specific Enteral Formula Improves Glycemic Variability in Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics. 12(6). 419–425. 55 indexed citations

20.

Parra, Esteban J., Rick A. Kittles, George Argyropoulos, et al.. (2001). Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. American Journal of Physical Anthropology. 114(1). 18–29. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact